{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:57:51Z","timestamp":1794283071915,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.urolonc.2013.10.012","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T16:45:24Z","timestamp":1384620324000},"page":"449-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure"],"prefix":"10.1016","volume":"32","author":[{"given":"Lu\u00eds","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresina","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2013.10.012_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.eururo.2013.05.027","article-title":"Maintenance bacillus Calmette-Gu\u00e9rin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence","volume":"64","author":"Ehdaie","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Gu\u00e9rin immunotherapy for superficial bladder cancer","volume":"170","author":"B\u00f6hle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/imt.10.32","article-title":"Recent advances in bacillus Calmette-Gu\u00e9rin immunotherapy in bladder cancer","volume":"2","author":"Alexandroff","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1016\/j.urolonc.2013.10.012_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2013.10.012_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/ATVBAHA.113.300168","article-title":"Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions","volume":"33","author":"Mantovani","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib9","first-page":"5857","article-title":"Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression","volume":"60","author":"Shimura","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.10.012_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/01913123.2012.728688","article-title":"Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy","volume":"37","author":"Ajili","year":"2013","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.juro.2008.11.090","article-title":"Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Gu\u00e9rin instillation","volume":"181","author":"Takayama","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib12","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.eururo.2009.01.040","article-title":"Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"55","author":"Ayari","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.canlet.2013.01.024","article-title":"Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer","volume":"332","author":"Tang","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.urolonc.2013.10.012_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-94-007-0782-5_7","article-title":"Expression of macrophage antigens by tumor cells","volume":"714","author":"Shabo","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib15","doi-asserted-by":"crossref","first-page":"181987","DOI":"10.1155\/2012\/181987","article-title":"Bladder Cancer Immunotherapy: BCG and beyond","volume":"2012","author":"Askeland","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4161\/onci.20640","article-title":"Blocking IL-10 enhances bacillus Calmette-Gu\u00e9rin induced T helper type 1 immune responses and anti-bladder cancer immunity","volume":"1","author":"Luo","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.urolonc.2013.10.012_bib17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","article-title":"Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect","volume":"21","author":"Luo","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.urolonc.2013.10.012_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ijc.21422","article-title":"Macrophage migration and gene expression in response to tumor hypoxia","volume":"117","author":"Murdoch","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2013.10.012_bib20","unstructured":"Oosterlinck W, van der Meijden A, Sylvester R, B\u00f6hle A, Rintala E, Solsona Narv\u00f3n E, et al. Guidelines on TaT1 (non-muscle invasive) bladder cancer. In: Office EG, editor. EAU Guidelines 2006. Arnhem (The Netherlands): EAU guidelines office; 2006."},{"key":"10.1016\/j.urolonc.2013.10.012_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Gu\u00e9rin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib22","doi-asserted-by":"crossref","first-page":"232609","DOI":"10.1155\/2012\/232609","article-title":"Predictive biomarkers of bacillus Calmette-Gu\u00e9rin immunotherapy response in bladder cancer: where are we now?","volume":"2012","author":"Lima","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2407-12-306","article-title":"The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients","volume":"12","author":"Medrek","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2013.10.012_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00277-012-1652-6","article-title":"Tumor-associated macrophages as a prognostic parameter in multiple myeloma","volume":"92","author":"Suyani","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/cas.12167","article-title":"Clinical significance of CD163 tumor-associated macrophages in patients with adult T-cell leukemia\/lymphoma","volume":"104","author":"Komohara","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2013.10.012_bib26","doi-asserted-by":"crossref","first-page":"e23562","DOI":"10.4161\/onci.23562","article-title":"Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma","volume":"2","author":"Dannenmann","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.urolonc.2013.10.012_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1442-2042.2000.00190.x","article-title":"Prognostic value of tumor-associated macrophage count in human bladder cancer","volume":"7","author":"Hanada","year":"2000","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2013.10.012_bib28","doi-asserted-by":"crossref","first-page":"e50946","DOI":"10.1371\/journal.pone.0050946","article-title":"Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2013.10.012_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0463.2008.00004.x","article-title":"Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis","volume":"117","author":"Chen","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.urolonc.2013.10.012_bib30","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/jcp.2007.050666","article-title":"Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma","volume":"61","author":"Chai","year":"2008","journal-title":"J Clin Pathol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913004547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913004547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:38Z","timestamp":1761040898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913004547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1078143913004547"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.10.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}